Characterizing the Plasmodium falciparum Subpellicular Network
描述恶性疟原虫表膜下网络的特征
基本信息
- 批准号:10733433
- 负责人:
- 金额:$ 2.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2024-05-29
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAntimalarialsArchitectureBiochemicalBiogenesisBiologyBloodCell ShapeCell membraneCellsCessation of lifeComplexCulicidaeCytoskeletal ProteinsCytoskeletonDaughterDefectDevelopmentDiseaseDrug TargetingEconomicsElectron MicroscopyErythrocytesEukaryotaFamilyFilamentFlow CytometryFluorescence-Activated Cell SortingHumanImmunofluorescence ImmunologicIndividualIntermediate FilamentsInvadedKnock-outLifeMalariaMammalian CellMapsMechanical StressMedicalMembraneMicroscopyMonitorMorphologyMotorNamesOrganellesParasitesPathway interactionsPatternPlasmidsPlasmodiumPlasmodium falciparumPlatinumPlayProcessProlineProtein FamilyProteinsProtozoaReproductionResearchRoleStainsStructureSystemTestingToxoplasma gondiiTransmission Electron MicroscopyValineasexualcell motilitydaughter celldrug developmentelectron tomographyinsightknock-downlive cell microscopynetwork architectureprotein functionreconstructionrhoptryscaffoldultra high resolution
项目摘要
ABSTRACT
The cytoskeleton of Plasmodium spp. is essential for replication, motility, and infectivity in both human and
mosquito life stages. P. falciparum, the causative agent of the most severe form of human malaria, leverages a
family of cytoskeletal proteins known as the alveolins to meet its diverse needs. These intermediate filament-like
proteins are absent outside the Alveolate kingdom, making them attractive drug targets. The alveolins have
stage-specific expression patterns and form an intricate lattice which envelops the parasite just below the pellicle,
another hallmark of Alveolata consisting of the parasite plasma membrane and inner membrane complex.
Remarkable progress has been achieved in characterizing the role of alveolins in P. berghei mosquito stages.
However, the functional role of individual alveolins in Plasmodium asexual stages remains unexplored. We have
recently demonstrated that the alveolin PfIMC1g is essential for P. falciparum asexual replication, but it remains
unclear what function this protein serves within the larger context of the Plasmodium cytoskeleton. Using
inducible knockdown (iKD) and knockout (iKO) systems in conjunction with super-resolution and platinum replica
electron microscopy, I will characterize the role of alveolin PfIMC1g (PF3D7_0525800) in P. falciparum daughter
cell segmentation and red blood cell invasion. This will elucidate its individual role in parasite cell shape and
ability to endure mechanical stress. In addition, I will use expansion microscopy to map the other alveolins
present in the asexual stages of the parasite, their interactions with each other, and test their essentiality for
daughter cell formation through conventional KO and iKO approaches. This research will increase our
understanding of the functional role that these building blocks of the P. falciparum SPN serve and determine
how they come together to enable its formation, function, and remodeling during segmentation. Together, these
insights into intermediate-filament-like cytoskeletal proteins and their organizing principles will bring us one step
closer to targeting these proteins with new antimalarial drugs.
摘要
疟原虫的细胞骨架。对人类和人类的复制、运动性和传染性都是必不可少的
蚊子的生活阶段。恶性疟原虫是人类最严重的疟疾的病原体,它利用一种
细胞骨架蛋白家族被称为肺泡蛋白,以满足其多样化的需求。这些中间细丝状
蛋白质不存在于蜂窝状王国之外,这使它们成为有吸引力的药物靶点。肺泡蛋白已经
阶段特定的表达模式,并形成一个复杂的晶格,将寄生虫包裹在膜的正下方,
肺泡菌的另一个特征是由寄生虫的质膜和内膜复合体组成。
在研究肺泡蛋白在伯氏疟原虫蚊虫发育阶段中的作用方面取得了显著进展。
然而,个体肺泡蛋白在疟原虫无性生殖阶段的功能作用仍未被探索。我们有
最近证明,肺泡素PfIMC1g对于恶性疟原虫的无性复制是必不可少的,但它仍然存在。
不清楚这种蛋白质在疟原虫细胞骨架的更大范围内起什么作用。vbl.使用
与超分辨率和白金复制品相结合的可诱导击倒(IKD)和击倒(IKO)系统
在电子显微镜下,我将表征肺泡素PfIMC1g(PF3D7_0525800)在恶性疟原虫子代中的作用
细胞分裂和红细胞入侵。这将阐明其在寄生虫细胞形态和
承受机械压力的能力。此外,我将使用扩张显微镜来绘制其他肺泡的图谱
存在于寄生虫的无性阶段,它们之间的相互作用,并测试它们对
通过传统的KO和IKO方法形成子代细胞。这项研究将增加我们的
对恶性疟原虫SPN的这些构件所起作用和决定作用的理解
它们是如何结合在一起,使其在分割过程中形成、功能和重塑的。加在一起,这些
对中间丝样细胞骨架蛋白及其组织原理的洞察将给我们带来一步
用新的抗疟疾药物更接近于靶向这些蛋白质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ana Karla Cepeda Diaz其他文献
Residues on Adeno-associated Virus Capsid Lumen Dictate Interactions and Compatibility with the Assembly-Activating Protein
腺相关病毒衣壳腔上的残留物决定了与组装激活蛋白的相互作用和相容性
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:5.4
- 作者:
Anna C. Maurer;Ana Karla Cepeda Diaz;L. Vandenberghe - 通讯作者:
L. Vandenberghe
Essential function of alveolin emPf/emIMC1g in the emPlasmodium falciparum/em asexual blood stage
肺泡蛋白 EMPlasmodium falciparum 无性血液阶段中 emPf/emIMC1g 的基本功能
- DOI:
10.1128/mbio.01507-23 - 发表时间:
2023-09-22 - 期刊:
- 影响因子:4.700
- 作者:
Ana Karla Cepeda Diaz;Rachel M. Rudlaff;Madeline Farringer;Jeffrey D. Dvorin - 通讯作者:
Jeffrey D. Dvorin
Ana Karla Cepeda Diaz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ana Karla Cepeda Diaz', 18)}}的其他基金
Characterizing the Plasmodium falciparum Subpellicular Network
描述恶性疟原虫表膜下网络的特征
- 批准号:
10533135 - 财政年份:2022
- 资助金额:
$ 2.65万 - 项目类别:
相似海外基金
Developing inhibitors of Plasmodium Acetyl CoA Synthetase as new multistage antimalarials
开发疟原虫乙酰辅酶A合成酶抑制剂作为新型多级抗疟药
- 批准号:
MR/X030202/1 - 财政年份:2023
- 资助金额:
$ 2.65万 - 项目类别:
Research Grant
Novel Dual-Stage Antimalarials: Machine learning prediction, validation and evolution
新型双阶段抗疟药:机器学习预测、验证和进化
- 批准号:
10742205 - 财政年份:2023
- 资助金额:
$ 2.65万 - 项目类别:
Natural Product Inspired Novel Antimalarials with Radical Cure Potential
受天然产物启发的具有根治潜力的新型抗疟药
- 批准号:
10635649 - 财政年份:2023
- 资助金额:
$ 2.65万 - 项目类别:
Novel Synergistic Antimalarials with Resistance Reversal Function
具有耐药逆转功能的新型协同抗疟药
- 批准号:
10534667 - 财政年份:2022
- 资助金额:
$ 2.65万 - 项目类别:
Plasmodium Protein Kinase Focused Antimalarials Discovery
疟原虫蛋白激酶聚焦抗疟药的发现
- 批准号:
10533634 - 财政年份:2022
- 资助金额:
$ 2.65万 - 项目类别:
DMPK Optimisation of B-hydroxyethylamine Antimalarials
B-羟乙胺抗疟药的 DMPK 优化
- 批准号:
2749037 - 财政年份:2022
- 资助金额:
$ 2.65万 - 项目类别:
Studentship
Development of new lead antimalarials targeting parasite coenzyme A biosynthesis and utilisation.
开发针对寄生虫辅酶 A 生物合成和利用的新型先导抗疟药。
- 批准号:
468862 - 财政年份:2022
- 资助金额:
$ 2.65万 - 项目类别:
Operating Grants
Repurposing antimalarials for the treatment of NTM infections
重新利用抗疟药治疗 NTM 感染
- 批准号:
10646331 - 财政年份:2022
- 资助金额:
$ 2.65万 - 项目类别:
Novel Synergistic Antimalarials with Resistance Reversal Function
具有耐药逆转功能的新型协同抗疟药
- 批准号:
10368441 - 财政年份:2022
- 资助金额:
$ 2.65万 - 项目类别:
Plasmodium Protein Kinase Focused Antimalarials Discovery
疟原虫蛋白激酶聚焦抗疟药的发现
- 批准号:
10663334 - 财政年份:2022
- 资助金额:
$ 2.65万 - 项目类别: